{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:47:06Z","timestamp":1782380826213,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute ischemic stroke (AIS) remains a leading cause of disability worldwide, and effective treatments are urgently needed beyond reperfusion therapy. Translating preclinical success to clinical impact has been hindered by variability in animal models and the lack of translational biomarkers that predict outcomes across species. To overcome these barriers, we developed a robust rat AIS model optimized for consistency and severity, enabling rigorous therapeutic testing. Additionally, we tested a panel of common clinical serum biomarkers to improve translation from rodents to humans. We demonstrated that serum neurofilament light chain (NfL) -a biomarker widely used in clinical stroke studies- strongly correlated with functional outcomes, establishing a translational link that has not been previously reported in rats. Notably, NfL\u2019s predictive capabilities performed as well as infarct volume while outperforming serum biomarkers intercellular adhesion molecule-1 (ICAM-1) and S100 calcium binding protein (S100B). Using this platform, we evaluated the therapeutic impact of neural stem cell-derived extracellular vesicles (NSC EV), a novel biologic therapy poised for clinical trials, on stroke outcome in our rat AIS model. A three-dose regimen of NSC EV over 48\u00a0h confirmed our previous studies and produced the best outcomes in stroked animals evidenced by smaller infarct volume, improved neurologic score, and reduced serum NfL. In addition, single-dose and two-dose regimens of NSC EV were both effective at some endpoints. These findings not only validate NfL as a cross-species biomarker but also provide critical dosing insights for NSC EV therapy, accelerating the path from bench to bedside for AIS treatment.<\/jats:p>","DOI":"10.1007\/s12975-026-01445-6","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:30:26Z","timestamp":1778225426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Neurofilament Light Chain Predicts Stroke Outcome and is a Potential Marker for Treatment Effects of Neural Stem Cell-derived Extracellular Vesicles in a Rat Stroke Model"],"prefix":"10.1007","volume":"17","author":[{"given":"Megan K.","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alinde R.","family":"Fojtik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Swetenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Stice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean I.","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily W.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"11","key":"1445_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S1474-4422(16)30177-6","volume":"15","author":"S Bracard","year":"2016","unstructured":"Bracard S, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15(11):1138\u201347.","journal-title":"Lancet Neurol"},{"issue":"10029","key":"1445_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723\u201331.","journal-title":"Lancet"},{"issue":"1","key":"1445_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira RG, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"1445_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s12975-019-00753-4","volume":"11","author":"SE Spellicy","year":"2020","unstructured":"Spellicy SE, et al. Neural Stem Cell Extracellular Vesicles Disrupt Midline Shift Predictive Outcomes in Porcine Ischemic Stroke Model. Transl Stroke Res. 2020;11(4):776\u201388.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"1445_CR5","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/STROKEAHA.117.020353","volume":"49","author":"RL Webb","year":"2018","unstructured":"Webb RL, et al. Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke. Stroke. 2018;49(5):1248\u201356.","journal-title":"Stroke"},{"issue":"5","key":"1445_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","volume":"9","author":"RL Webb","year":"2018","unstructured":"Webb RL, et al. Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model. Transl Stroke Res. 2018;9(5):530\u20139.","journal-title":"Transl Stroke Res"},{"key":"1445_CR7","doi-asserted-by":"crossref","unstructured":"Spellicy S et al. Reduced acute ischemic stroke-induced neural inflammation using neural stem cell-derived extracellular vesicles (AB126). 2024.","DOI":"10.20944\/preprints202404.0216.v1"},{"key":"1445_CR8","doi-asserted-by":"publisher","first-page":"619721","DOI":"10.3389\/fneur.2021.619721","volume":"12","author":"M Dagonnier","year":"2021","unstructured":"Dagonnier M, et al. Acute stroke biomarkers: are we there yet? Front Neurol. 2021;12:619721.","journal-title":"Front Neurol"},{"issue":"8","key":"1445_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-025-01165-w","volume":"24","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, et al. Biomarker-guided decision making in clinical drug development for neurodegenerative disorders. Nat Rev Drug Discov. 2025;24(8):589\u2013609.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1445_CR10","doi-asserted-by":"publisher","first-page":"e0140668","DOI":"10.1371\/journal.pone.0140668","volume":"10","author":"M Rodier","year":"2015","unstructured":"Rodier M, et al. Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment. PLoS ONE. 2015;10(10):e0140668.","journal-title":"PLoS ONE"},{"issue":"15","key":"1445_CR11","doi-asserted-by":"publisher","first-page":"e1928","DOI":"10.1212\/WNL.0000000000011742","volume":"96","author":"A Bustamante","year":"2021","unstructured":"Bustamante A, et al. Blood Biomarkers to Differentiate Ischemic and Hemorrhagic Strokes. Neurology. 2021;96(15):e1928\u201339.","journal-title":"Neurology"},{"issue":"8","key":"1445_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamaneurol.2023.1660","volume":"80","author":"M Hernandez-Jimenez","year":"2023","unstructured":"Hernandez-Jimenez M, et al. Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1\/2 Randomized Clinical Trial. JAMA Neurol. 2023;80(8):779\u201388.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1445_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess DC, et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(5):360\u20138.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1445_CR14","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","volume":"32","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012;32(9):1677\u201398.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"22","key":"1445_CR15","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000012918","volume":"97","author":"S Luger","year":"2021","unstructured":"Luger S, et al. Role of S100B Serum Concentration as a Surrogate Outcome Parameter After Mechanical Thrombectomy. Neurology. 2021;97(22):e2185\u201394.","journal-title":"Neurology"},{"issue":"1","key":"1445_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainres.2006.12.025","volume":"1137","author":"Y Tanaka","year":"2007","unstructured":"Tanaka Y, et al. Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model. Brain Res. 2007;1137(1):140\u20135.","journal-title":"Brain Res"},{"key":"1445_CR17","doi-asserted-by":"publisher","first-page":"107907","DOI":"10.1016\/j.clineuro.2023.107907","volume":"233","author":"AMA Hawash","year":"2023","unstructured":"Hawash AMA, et al. S100B and brain ultrasound: Novel predictors for functional outcome in acute ischemic stroke patients. Clin Neurol Neurosurg. 2023;233:107907.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1\u20132","key":"1445_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000090005","volume":"21","author":"JY Wang","year":"2006","unstructured":"Wang JY, et al. Association of soluble intercellular adhesion molecule 1 with neurological deterioration of ischemic stroke: The Chongqing Stroke Study. Cerebrovasc Dis. 2006;21(1\u20132):67\u201373.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1445_CR19","first-page":"767083","volume":"2011","author":"I Dujmovic","year":"2011","unstructured":"Dujmovic I. Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Multiple Scler Int. 2011;2011(1):767083.","journal-title":"Multiple Scler Int"},{"issue":"5","key":"1445_CR20","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, et al. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996;67(5):2013\u20138.","journal-title":"J Neurochem"},{"issue":"6","key":"1445_CR21","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","volume":"95","author":"P Shahim","year":"2020","unstructured":"Shahim P, et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020;95(6):e610\u201322.","journal-title":"Neurology"},{"issue":"8","key":"1445_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, et al. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1445_CR23","doi-asserted-by":"publisher","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan A, Nixon RA. Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front NeuroSci. 2021;15:689938.","journal-title":"Front NeuroSci"},{"issue":"1","key":"1445_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","volume":"73","author":"H Zetterberg","year":"2016","unstructured":"Zetterberg H, et al. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 2016;73(1):60\u20137.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1445_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, et al. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74(5):557\u201366.","journal-title":"JAMA Neurol"},{"issue":"9","key":"1445_CR26","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino J, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE. 2013;8(9):e75091.","journal-title":"PLoS ONE"},{"issue":"39","key":"1445_CR27","doi-asserted-by":"publisher","first-page":"e30849","DOI":"10.1097\/MD.0000000000030849","volume":"101","author":"JW Ahn","year":"2022","unstructured":"Ahn JW, et al. Serum neurofilament light chain levels are correlated with the infarct volume in patients with acute ischemic stroke. Medicine. 2022;101(39):e30849.","journal-title":"Medicine"},{"issue":"3","key":"1445_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ene.13554","volume":"25","author":"G De Marchis","year":"2018","unstructured":"De Marchis G, et al. Serum neurofilament light chain in patients with acute cerebrovascular events. Eur J Neurol. 2018;25(3):562\u20138.","journal-title":"Eur J Neurol"},{"issue":"8","key":"1445_CR29","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.008","volume":"28","author":"J Onatsu","year":"2019","unstructured":"Onatsu J, et al. Serum neurofilament light chain concentration correlates with infarct volume but not prognosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(8):2242\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"1445_CR30","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00415-019-09477-9","volume":"266","author":"A Pedersen","year":"2019","unstructured":"Pedersen A, et al. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction. J Neurol. 2019;266(11):2796\u2013806.","journal-title":"J Neurol"},{"issue":"14","key":"1445_CR31","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","volume":"91","author":"S Tiedt","year":"2018","unstructured":"Tiedt S, et al. Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke. Neurology. 2018;91(14):e1338\u201347.","journal-title":"Neurology"},{"key":"1445_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fneur.2020.00448","volume":"11","author":"HH Nielsen","year":"2020","unstructured":"Nielsen HH, et al. Acute neurofilament light chain plasma levels correlate with stroke severity and clinical outcome in ischemic stroke patients. Front Neurol. 2020;11:448.","journal-title":"Front Neurol"},{"issue":"11","key":"1445_CR33","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1161\/STROKEAHA.119.026410","volume":"50","author":"T Uphaus","year":"2019","unstructured":"Uphaus T, et al. NfL (neurofilament light chain) levels as a predictive marker for long-term outcome after ischemic stroke. Stroke. 2019;50(11):3077\u201384.","journal-title":"Stroke"},{"issue":"9","key":"1445_CR34","doi-asserted-by":"publisher","first-page":"100614","DOI":"10.1016\/j.jlr.2024.100614","volume":"65","author":"DA Becktel","year":"2024","unstructured":"Becktel DA, et al. Discovering novel plasma biomarkers for ischemic stroke: Lipidomic and metabolomic analyses in an aged mouse model. J Lipid Res. 2024;65(9):100614.","journal-title":"J Lipid Res"},{"issue":"12","key":"1445_CR35","doi-asserted-by":"publisher","first-page":"e16118","DOI":"10.14814\/phy2.16118","volume":"12","author":"DP Murphy","year":"2024","unstructured":"Murphy DP, et al. Chronic consequences of ischemic stroke: Profiling brain injury and inflammation in a mouse model with reperfusion. Physiol Rep. 2024;12(12):e16118.","journal-title":"Physiol Rep"},{"key":"1445_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3995\/jstroke.8.1","volume":"8","author":"J Koizumi","year":"1986","unstructured":"Koizumi J. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1\u20138.","journal-title":"Jpn J Stroke"},{"issue":"1","key":"1445_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84\u201391.","journal-title":"Stroke"},{"issue":"5","key":"1445_CR38","doi-asserted-by":"publisher","first-page":"H1192","DOI":"10.1152\/ajpheart.00446.2018","volume":"316","author":"W Eldahshan","year":"2019","unstructured":"Eldahshan W, et al. Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. Am J Physiol Heart Circ Physiol. 2019;316(5):H1192\u2013201.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1445_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/01.STR.0000113692.38574.57","volume":"35","author":"T Gerriets","year":"2004","unstructured":"Gerriets T, et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke. 2004;35(2):566\u201371.","journal-title":"Stroke"},{"issue":"3","key":"1445_CR40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","volume":"17","author":"JB Bederson","year":"1986","unstructured":"Bederson JB, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472\u20136.","journal-title":"Stroke"},{"issue":"4","key":"1445_CR41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s12975-019-00753-4","volume":"11","author":"SE Spellicy","year":"2020","unstructured":"Spellicy SE, et al. Neural stem cell extracellular vesicles disrupt midline shift predictive outcomes in porcine ischemic stroke model. Translational stroke Res. 2020;11(4):776\u201388.","journal-title":"Translational stroke Res"},{"issue":"8","key":"1445_CR42","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.ymthe.2018.05.019","volume":"26","author":"G Fernandez","year":"2018","unstructured":"Fernandez G, et al. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models. Mol Ther. 2018;26(8):2047\u201359.","journal-title":"Mol Ther"},{"issue":"5","key":"1445_CR43","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/stem.2600","volume":"35","author":"B Yang","year":"2017","unstructured":"Yang B, et al. Multipotent Adult Progenitor Cells Enhance Recovery After Stroke by Modulating the Immune Response from the Spleen. Stem Cells. 2017;35(5):1290\u2013302.","journal-title":"Stem Cells"},{"key":"1445_CR44","unstructured":"DJB et al. Progress update on the phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of arg-007 in acute ischemic stroke patients (SEANCON). in Asia Pacific Stroke Conference 2024. Adelaide, Australia."},{"issue":"1","key":"1445_CR45","doi-asserted-by":"publisher","first-page":"e2456535","DOI":"10.1001\/jamanetworkopen.2024.56535","volume":"8","author":"JS Lee","year":"2025","unstructured":"Lee JS, et al. Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial. JAMA Netw Open. 2025;8(1):e2456535.","journal-title":"JAMA Netw Open"},{"key":"1445_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.brainres.2008.06.076","volume":"1227","author":"Y Tanaka","year":"2008","unstructured":"Tanaka Y, et al. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia. Brain Res. 2008;1227:248\u201354.","journal-title":"Brain Res"},{"key":"1445_CR47","doi-asserted-by":"publisher","first-page":"p5539304","DOI":"10.1155\/2021\/5539304","volume":"2021","author":"L Wang","year":"2021","unstructured":"Wang L, et al. Serum ICAM-1 as a Predictor of Prognosis in Patients with Acute Ischemic Stroke. Biomed Res Int. 2021;2021:p5539304.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1445_CR48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/02699052.2014.989403","volume":"29","author":"Z Olivecrona","year":"2015","unstructured":"Olivecrona Z, Bobinski L, Koskinen L-OD. Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers. Brain Injury. 2015;29(4):446\u201354.","journal-title":"Brain Injury"},{"issue":"10","key":"1445_CR49","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/01.STR.29.10.2129","volume":"29","author":"A Bitsch","year":"1998","unstructured":"Bitsch A, et al. A Longitudinal Prospective Study of Soluble Adhesion Molecules in Acute Stroke. Stroke. 1998;29(10):2129\u201335.","journal-title":"Stroke"},{"key":"1445_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-2094-7-74","volume":"7","author":"AG Ceulemans","year":"2010","unstructured":"Ceulemans AG, et al. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010;7:74.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1445_CR51","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s12640-019-00159-y","volume":"37","author":"P Wang","year":"2020","unstructured":"Wang P, et al. Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke. Neurotox Res. 2020;37(4):987\u201395.","journal-title":"Neurotox Res"},{"issue":"26","key":"1445_CR52","doi-asserted-by":"publisher","first-page":"e29692","DOI":"10.1097\/MD.0000000000029692","volume":"101","author":"J Wu","year":"2022","unstructured":"Wu J, et al. Plasma neurofilament light chain: A biomarker predicting severity in patients with acute ischemic stroke. Med (Baltim). 2022;101(26):e29692.","journal-title":"Med (Baltim)"},{"key":"1445_CR53","unstructured":"Steffen Tiedt TF, Petzold G, Pham M, Swartz R, Poli S, J\u00f6rg, Berrouschot et al. Neurofilament light as a marker of neuroaxonal injury in the escape-next. in 11th European Stroke Organisation Conference. 2025. Helsinki, Finland."},{"issue":"3","key":"1445_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00281-023-00987-3","volume":"45","author":"IS Schadlich","year":"2023","unstructured":"Schadlich IS, et al. The role of the ATP-adenosine axis in ischemic stroke. Semin Immunopathol. 2023;45(3):347\u201365.","journal-title":"Semin Immunopathol"},{"key":"1445_CR55","doi-asserted-by":"crossref","unstructured":"ISEV2023 Abstract Book. J Extracell Vesicles. 2023;12(Suppl 1).","DOI":"10.1002\/jev2.12329"},{"issue":"6","key":"1445_CR56","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.jcbfm.9600229","volume":"26","author":"OB Dimitrijevic","year":"2006","unstructured":"Dimitrijevic OB, et al. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2006;26(6):797\u2013810.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1445_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/jir.2023.0132","volume":"44","author":"L Chen","year":"2024","unstructured":"Chen L, et al. C-C Motif Chemokine 2 Regulates Macrophage Polarization and Contributes to Myocardial Infarction Healing. J Interferon Cytokine Res. 2024;44(2):68\u201379.","journal-title":"J Interferon Cytokine Res"},{"issue":"13","key":"1445_CR58","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317\u201329.","journal-title":"N Engl J Med"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01445-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-026-01445-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01445-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:02:19Z","timestamp":1782378139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-026-01445-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1007\/s12975-026-01445-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.01.28.702334","asserted-by":"object"}]},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Aruna Bio, Inc. has granted patents for NSC EV composition of matter and as a method for treating stroke and brain inflammation. S.L.S. owns equity shares in Aruna Bio. M.K.C., A.R.F, C.M.W., R.L.S., S.L.S. and E.W.B. were employees of Aruna Bio while engaged in the research project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}